Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 56 results found. Search for [ Dr Reddy's Laboratories share price ]

Results 1 to 21 of 56
BusinessToday.In
New Delhi, February 15, 2019
Reacting to the news, shares of the pharma major declined as much as 22 per cent amid heavy volume to touch an intra-day low of Rs 2,065.30 apiece on the BSE, after opening lower at Rs 2650.10 against previous closing price of 2669.30.


BusinessToday.In
February 11, 2019
The Dr Reddy's Laboratories share opened at a loss of 3.69% at 2,670 today compared to the previous close of 2,772.30 on the BSE. The Dr Reddy's Laboratories stock further crashed 216 points or 7.81% to 2555.5 level on the BSE.


BusinessToday.In
December 12, 2018
The stock fell 5.16% intra day to 2569 level on the BSE. The large cap stock has fallen after two days of consecutive gain. On NSE, the stock fell 5.45% to 2,568 level. The stock was the top loser on Nifty.


BusinessToday.In
November 21, 2018
Suboxone is British drugmaker Indivior's best-selling opioid addiction treatment drug in the US. Shares of Indivior tanked about 47 percent on Tuesday, in a record single-day fall. Jefferies analysts said they consider the ruling to be near-term positive, and one that allows the company to immediately re-launch the product, but still at-risk.


BusinessToday.In
November 6, 2018
A day before Diwali and on the last day of Samvat 2074, here's a look at the stock recommendations by Epic Research and Way2Wealth, which are likely to be the best picks for Samvat 2075.


BusinessToday.In
October 31, 2018
The brokerage is concerned about patchy monsoon, election season, rising twin deficits, high crude prices, weak INR, slowing Chinese economy, trade wars, etc.  It wonders whether the market will recover at all or whether a bear market is the next phase?


PB Jayakumar
New Delhi, October 29, 2018
A big transformation is happening in the global generic pharmaceutical industry. As a result, stocks of most major drug companies have done badly in the past one year.


BusinessToday.In
July 16, 2018
The Dr Reddy's stock fell up to 10.61% or 246 points to 2,071.50 level. The stock closed 9.85% or 228 points lower at 2089.15 on the BSE.


BusinessToday.In
May 23, 2018
The Sensex and Nifty closed lower today dragged by energy stocks such as Hindustan Petroleum Corp and Oil and Natural Gas Corp on rising concern that the government may ask state-owned oil firms to share the burden of higher petrol and diesel prices.The broader NSE Nifty closed 1.01 percent lower at 10,430, while the benchmark BSE Sensex fell 0.88 percent to 34,344. Both the indexes fell over 1 percent in the last hour of trading. SBI was the top Sensex gainer after the bank sai...


BusinessToday.In
May 23, 2018
The broader NSE Nifty closed 1.01 percent or 106 points lower at 10,430.35, while the benchmark BSE Sensex fell 0.88 percent or 306 points to 34,344.91. Both the indexes fell over 1 percent in the last hour of trading.


P.B. Jayakumar
New Delhi, April 30, 2018
Drug companies are moving up the value chain, transforming into complex generic manufacturers with high end R&D facilities.


Reuters
New Delhi, November 17, 2017
Reuters has documented at least 12 cases of prescient messages about major Indian companies, including Dr. Reddy's, being posted in private WhatsApp groups.


Reuters
November 16, 2017
Three days before Dr. Reddy's Laboratories Ltd announced quarterly results this summer, a message circulated on a private WhatsApp group saying the Indian drugmaker would not post good numbers.


E Kumar Sharma
November 3, 2017
The list includes names of some of India's leading pharmaceutical companies like Sun Pharma, Dr Reddy's, Glenmark and Aurobindo.


BT Online
October 31, 2017
The Bharti Airtel stock closed 1.29 percent or 6.35 points higher at 499.15 level ahead of its Q2 earnings to be announced today. Meanwhile, Hindustan Petroleum Corp Ltd (HPCL) is likely to buy Mangalore Refinery and Petrochemicals (MRPL) in a share-swap deal to become country's second-largest oil refiner.


By E. Kumar Sharma,E Kumar Sharma
Delhi, October 29, 2016
Many major pharma stocks, seen as safe bets in the worst of times, have seen their market caps slip in the past year. Is pharma losing its sheen on the bourses?


BT Online
New Delhi, May 13, 2016
The headline indices fell more than 1 per cent after stronger-than-expected consumer inflation data raised the prospect the Reserve Bank of India would keep interest rates on hold.


Ajay Tyagi and Munish Shekhavat
New Delhi, December 23, 2015
Globally also, it remained a year marked with record mergers, led by the $160 billion deal between Viagra maker Pfizer Inc and Botox manufacturer Allergan.


Reuters
Singapore/Mumbai, September 3, 2015
In trading so far this year, Lupin has climbed 32 per cent, Dr. Reddy's 31 per cent, Glenmark Pharmaceuticals 42 per cent and Wockhardt 29 per cent.


BT Online Bureau
New Delhi, July 14, 2015
Essel Propack has sold its wholly owned subsidiary Packaging India Pvt Ltd, valued at Rs 165 crore, to Amcor Flexibles India Pvt Ltd.


PAGES 1 OF 3  123